Skip to content

Influence of circadian rhythms on pharmacokinetics of rocuronium: a prospective, single-center, single-arm clinical study

Influence of circadian rhythms on pharmacokinetics of rocuronium: a prospective, single-center, single-arm clinical study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400081997
Enrollment
Unknown
Registered
2024-03-18
Start date
2024-03-19
Completion date
Unknown
Last updated
2024-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

No disease involved

Interventions

Morning group 08:00 ~ 10:00 (group A) :NA
Afternoon group 14:00-16:00 (group B):NA
Night group 21:00-23:00 (group C):NA

Sponsors

Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1: Age between 30 and 60 years old (including boundary values) 2: Patients with laparoscopic cholecystectomy or laparoscopic appendectomy who meet the criteria for general anesthesia 3: BMI between 18 and 24 (including boundary values) 4: Classified as ASA grade I-II 5: The Child's grade was A 6: Volunteer to participate in the study and sign the informed consent If the subject is not capable of reading the informed consent (such as illiterate subjects), a witness should witness the informed process and sign the informed consen

Exclusion criteria

Exclusion criteria: 1: Breastfeeding and pregnancy, or planning pregnancy within 6 months 2: Patients who have performed cardiopulmonary resuscitation before and have not recovered their neurological function 3: Patients with a history of severe cardiovascular respiratory renal liver hematologic malignancies or immune diseases: heart failure greater than NYHA Grade II 4: For active myocardial ischemia, cardiovascular intervention was performed within 60 days 5: History of cirrhosis 6: Chronic kidney disease, creatinine clearance < 40 mL/min 7: Chronic obstructive pulmonary disease requiring home oxygen therapy

Design outcomes

Primary

MeasureTime frame
Drug concentration;Apparent Clearance Rate;Apparent volume of distribution;Half-life period;Area under the curve;

Countries

China

Contacts

Public ContactXin Yu

Sir Run Run Shaw Hospital, Zhejiang University School of Medicine

xinxin_yu@zju.edu.cn+86 135 8870 8514

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026